标题
Duchenne muscular dystrophy: an historical treatment review
作者
关键词
-
出版物
ARQUIVOS DE NEURO-PSIQUIATRIA
Volume 77, Issue 8, Pages 579-589
出版商
FapUNIFESP (SciELO)
发表日期
2019-09-05
DOI
10.1590/0004-282x20190088
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
- (2018) Craig M McDonald et al. LANCET
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Deflazacort vs prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post hoc analysis from the ACT DMD trial
- (2018) Perry B Shieh et al. MUSCLE & NERVE
- Eteplirsen treatment for Duchenne muscular dystrophy
- (2018) Jay S. Charleston et al. NEUROLOGY
- A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
- (2018) Nathalie Goemans et al. NEUROMUSCULAR DISORDERS
- Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis
- (2018) Yuko Shimizu-Motohashi et al. Orphanet Journal of Rare Diseases
- Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy
- (2018) Craig M. McDonald et al. Annals of Clinical and Translational Neurology
- Clinical management of Duchenne muscular dystrophy: the state of the art
- (2018) Sonia Messina et al. NEUROLOGICAL SCIENCES
- Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Craig M McDonald et al. LANCET
- A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy
- (2017) Ronald G. Victor et al. NEUROLOGY
- Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
- (2017) Luca Parente BMC Pharmacology & Toxicology
- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Proposing a mechanism of action for ataluren
- (2016) Nadeem Siddiqui et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Short stature and pubertal delay in Duchenne muscular dystrophy
- (2015) Claire L Wood et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial
- (2015) Gunnar M Buyse et al. LANCET
- Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy
- (2015) Stephen Lynn et al. NEUROMUSCULAR DISORDERS
- Ataluren treatment of patients with nonsense mutation dystrophinopathy
- (2014) Katharine Bushby et al. MUSCLE & NERVE
- Pentoxifylline as a rescue treatment for DMD: A randomized double-blind clinical trial
- (2012) D. M. Escolar et al. NEUROLOGY
- Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure
- (2012) Meilan M. Rutter et al. NEUROMUSCULAR DISORDERS
- CINRG pilot trial of coenzyme Q10 in steroid-treated duchenne muscular dystrophy
- (2011) Christopher F. Spurney et al. MUSCLE & NERVE
- Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial
- (2010) Janbernd Kirschner et al. LANCET NEUROLOGY
- Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment
- (2010) M. L. Bianchi et al. OSTEOPOROSIS INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started